ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q3 EPS of ($0.21), $0.03 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $8.86 million versus the consensus estimate of $9.8 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.